ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 234 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $123,334,921 | – | 2,673,638 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 39,362 | $1,749,000 | 4.12% |
| First Light Asset Management, LLC | 342,603 | $15,222,000 | 2.60% |
| EcoR1 Capital, LLC | 371,208 | $16,493,000 | 1.72% |
| SECTOR GAMMA AS | 145,072 | $6,446,000 | 1.37% |
| Rock Springs Capital Management LP | 747,800 | $33,225,000 | 1.37% |
| Capital Impact Advisors, LLC | 45,922 | $2,040,000 | 0.86% |
| Cinctive Capital Management LP | 60,033 | $2,667,000 | 0.59% |
| FEDERATED HERMES, INC. | 4,016,760 | $178,465,000 | 0.52% |
| Rhenman & Partners Asset Management AB | 68,524 | $3,045,000 | 0.43% |
| Capital International, Inc./CA/ | 450,495 | $20,015,000 | 0.34% |